Tempus AI Total Common and Preferred Stock Dividends Paid 2023-2025 | TEM

Tempus AI annual/quarterly total common and preferred stock dividends paid history and growth rate from 2023 to 2025. Total common and preferred stock dividends paid can be defined as the cash outflow for all company dividends paid out to preferred and common shareholders.
  • Tempus AI total common and preferred stock dividends paid for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Tempus AI total common and preferred stock dividends paid for the twelve months ending March 31, 2025 were $-0.017B, a 0% increase year-over-year.
  • Tempus AI annual total common and preferred stock dividends paid for 2024 were $-0.006B, a 0% decline from 2023.
  • Tempus AI annual total common and preferred stock dividends paid for 2023 were $-0.006B, a 0% decline from 2022.
  • Tempus AI annual total common and preferred stock dividends paid for 2022 were $-0.006B, a 0% decline from .
Tempus AI Annual Total Common and Preferred Stock Dividends Paid
(Millions of US $)
2024 $-6
2023 $-6
2022 $-6
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.830B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.908B 52.36
Hims & Hers Health (HIMS) United States $12.273B 127.51
IRhythm Technologies (IRTC) United States $4.555B 0.00
Inspire Medical Systems (INSP) United States $4.224B 66.00
Privia Health (PRVA) United States $2.787B 190.50
Enovis (ENOV) United States $1.803B 10.05
Clover Health Investments (CLOV) United States $1.623B 0.00
Schrodinger (SDGR) United States $1.570B 0.00
Phreesia (PHR) United States $1.431B 0.00
Omnicell (OMCL) United States $1.322B 23.33
Azenta (AZTA) United States $1.236B 57.45
10x Genomics (TXG) United States $1.006B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.537B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.472B 141.00
Claritev (CTEV) United States $0.437B 0.00
TruBridge (TBRG) United States $0.357B 791.00
Standard BioTools (LAB) United States $0.350B 0.00
Outset Medical (OM) United States $0.318B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.190B 0.00
EUDA Health Holdings (EUDA) Singapore $0.140B 0.00
Pulmonx (LUNG) United States $0.125B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
CareCloud (CCLD) United States $0.084B 3.21
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00